ArticleNPJ precision oncology2026

Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson.

Jeong Uk Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.